the lymphoseek market is about 150 million but they would get the whole market because doctors don't usually use a drug off-label if there is one approved for the indication.
The lymphoseek also works better and faster.
I am almost positive it goes to phase 3 within a few months and it is a diagnostic so the trial is short and we know it works from the previous trial. None of it is priced into the stock.
the rigs drug can be a billion dollar drug. Drug prices have gone up a lot since 1997.
This stock had a market cap of 450 million when neoprobe was in the fda process with the bla in 1997. this story is so far under the radar screen that it's crashed and burned, but like the phoenix it will be resurected
Are you buying any. I have a few hundred thousand shares.
Market Data 
Markets 
AI
